SYRE
Spyre Therapeutics, Inc.
+1.41 (+1.54%)92.58USD357K成交股數8.2B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | 0.00 | 0.00-100% | 0.00-100% | 0.00 | 0.00 | 688K | 198K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 65.5M | 60.4M | 45.2M | 40.1M | 41.6M | 50.5M | 44.7M | 32.6M | 34.9M | 24.7M | 17.4M | 13.8M |
| 銷售管理費用 | 16.1M | 15.2M | 11.6M | 11.8M | 11.9M | 10.8M | 10.6M | 11.5M | 12.8M | 8.6M | 12.1M | 5.2M |
| 營業利益 | −41.6M-22% | −45.6M-25% | −56.9M+3% | −41.9M-5% | −53.6M+12% | −61.3M+234% | −55.4M-65% | −44.1M+135% | −47.8M | −18.3M | −159M | −18.8M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | -23,146.2% | -9,498.0% |
| 稅後淨利 | −36.2M-19% | −69.0M+23% | −11.2M-84% | −36.7M-5% | −44.8M+2% | −56.3M+40% | −69.0M-68% | −38.8M+111% | −43.9M | −40.1M | −217M | −18.4M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | -31,552.5% | -9,304.0% |
| 稀釋 EPS | – | -0.74 | – | – | – | – | 1.06-97% | 0.59-112% | 0.72 | 0.86 | 40.14 | -4.89 |
| 稀釋股數 | – | – | – | – | – | – | 50.9M | 45.3M | 36.5M | 4.3M | 3.8M | 3.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 162M | 97.2M | 64.9M | 81.7M | 48.5M | 89.4M | 71.6M | 45.1M | 228M | 90.6M | 235M | 35.2M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.2B | 764M | 505M | 539M | 570M | 608M | 421M | 436M | 488M | 207M | 244M | 52.5M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 71.9M | 93.1M | 49.5M | 83.1M | 87.2M | 90.7M | 93.7M | 61.7M | 81.9M | 65.6M | 254M | 18.8M |
| 股東權益 | 1.1B | 671M | 455M | 456M | 483M | 518M | 327M | 374M | 152M | −245M | −207M | 33.7M |
| 負債比 | 6.1% | 12.2% | 9.8% | 15.4% | 15.3% | 14.9% | 22.3% | 14.1% | 16.8% | 31.6% | 104.1% | 35.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −57.4M | – | – | −41.0M+44% | – | – | – | −28.5M | – | – | −17.6M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | 0.00 | – | – | 384K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 0.00 | – | −155M | –% | – | – |
| FY2024 | 0.00 | -100.0% | −208M | –% | – | −157M |
| FY2023 | 886K | -62.0% | −339M | -38,238.1% | 13.76 | −99.9M |
| FY2022 | 2.3M | -87.6% | −83.8M | -3,598.8% | -24.86 | −80.2M |
| FY2021 | 18.7M | – | −65.8M | -351.1% | -25.02 | −54.3M |
| FY2020 | 0.00 | – | −80.9M | –% | -1.52 | −80.1M |
| FY2019 | 0.00 | -100.0% | −78.3M | –% | -2.45 | −67.2M |
| FY2018 | 3.9M | – | −44.3M | -1,140.6% | -2.13 | −32.6M |